Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,102 | -25,546 | -28,275 | -53,981 | -41,226 |
| Depreciation Amortization | 25,212 | 57,947 | 42,606 | 26,818 | 12,802 |
| Accounts receivable | -7,225 | -27,822 | -55,641 | -11,486 | -7,204 |
| Accounts payable and accrued liabilities | -11,809 | -85 | -6,332 | -5,223 | -8,305 |
| Other Working Capital | -45,118 | -13,997 | -66,663 | -29,331 | -23,693 |
| Other Operating Activity | 35,676 | 47,287 | 91,411 | 35,992 | 25,432 |
| Operating Cash Flow | $-40,366 | $37,784 | $-22,894 | $-37,211 | $-42,194 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 43,727 | 86,453 | 171,958 | 70,182 | 53,157 |
| PPE Investments | N/A | N/A | -375 | -235 | N/A |
| Purchase Sale Intangibles | -22,178 | -58,157 | -38,918 | -23,870 | -11,784 |
| Other Investing Activity | -22,178 | -58,561 | -38,852 | -23,807 | -11,867 |
| Investing Cash Flow | $21,549 | $27,892 | $132,731 | $46,140 | $41,290 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,729 | 34,745 | 8,796 | 4,706 | 4,243 |
| Other Financing Activity | -525 | -68,212 | -68,942 | 487 | -525 |
| Financing Cash Flow | $4,204 | $-33,467 | $-60,146 | $5,193 | $3,718 |
| Exchange Rate Effect | -60 | 2,291 | 2,704 | 2,497 | 548 |
| Beginning Cash Position | 93,035 | 58,535 | 58,535 | 58,535 | 58,535 |
| End Cash Position | 78,362 | 93,035 | 110,930 | 75,154 | 61,897 |
| Net Cash Flow | $-14,673 | $34,500 | $52,395 | $16,619 | $3,362 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,366 | 37,784 | -22,894 | -37,211 | -42,194 |
| Capital Expenditure | N/A | N/A | -375 | -235 | N/A |
| Free Cash Flow | -40,366 | 37,784 | -23,269 | -37,446 | -42,194 |